References
- Dressman JB, Reppas C. In vitro-in vivo correlations for lipophilic poorly water- soluble drugs. Eur J Pharm Sci 2000; 11: S73–S80.
- Khan KA. The concept of dissolution efficiency. J Pharm Pharmacol 1975; 27, 48–49.
- Khan MJI. Dissolution testing for sustained or controlled release oral dosage forms and correlation with in vivo data: challenges and opportunities. Int J Pharm 1996; 140, 131–143.
- Khan GM, Zhu JB. Studies on drug release kinetics from ibuprofen–carbomer hydrophilic matrix tablets: influence of co-excipients on release rate of the drug. J Control Release 1999; 57 (2), 197–203.
- Moore JW, Flanner HH. Mathematical comparison of curves with an emphasis on in vitro dissolution profiles. Pharm Technol 1996; 20, 64–74.
- Rowe RC, Sheskey PJ, Quinn ME. Handbook Of Pharmaceutical Excipients. London: Pharmaceutical Press, 2009: 96–99.
- Sood Anurag Panchagnula, Ramesh. Design of controlled release delivery systems using a modified pharmacokinetic approach: a case study for drugs having a short elimination half-life and a narrow therapeutic index. Int J Pharm 2003; 261, 27–41.
- Sutananata W, Craig DQM, Newton JM. An evaluation of the mechanism of drug release from glyceride bases. J Pharm Pharmacol 1995a; 47, 182–187.
- Sutananata W, Craig DQM, Newton JM. An investigation into the effects of preparation conditions and storage on the rate of drug release from pharmaceutical glycerides bases. J Pharm Pharmacol 1995b; 47, 355–359.
- Voegele D, Brockmeier D, Von Hattingberg HM, Lippold BC. Die mittlere Auflösezeit—ein parameter zur prüfung von liberationsbedingungen auf vergleichbarkeit. Acta Pharm Techno 1983;29, 167–174
- Wells JI (1997). Tablet testing. In: Swarbrick J, Boylan JC, eds. Encyclopedia of Pharmaceutical Technology. Marcel Dekker: New York, Vol. 14, 1997: 401–418.